about
Expression of STAT5, COX-2 and PIAS3 in correlation with NSCLC histhopathological features.Altered miRNA expression in pulmonary sarcoidosis.CTLA-4 gene polymorphisms and their influence on predisposition to autoimmune thyroid diseases (Graves' disease and Hashimoto's thyroiditis).Immunoexpression of TGF-β/Smad and VEGF-A proteins in serum and BAL fluid of sarcoidosis patientsRearrangements of NTRK1 oncogene in papillary thyroid carcinoma.Significant frequency of allelic imbalance in 3p region covering RARβ and MLH1 loci seems to be essential in molecular non-small cell lung cancer diagnosis.Ctla-4 expression and polymorphisms in lung tissue of patients with diagnosed non-small-cell lung cancer.Allelic imbalance in 1p, 7q, 9p, 11p, 12q and 16q regions in non-small cell lung carcinoma and its clinical association: a pilot study.A minireview: the role of MAPK/ERK and PI3K/Akt pathways in thyroid follicular cell-derived neoplasm.MSI and LOH in the development and prognosis of follicular cell-derived thyroid tumours.Analysis of changes in expression of IL-4/IL-13/STAT6 pathway and correlation with the selected clinical parameters in patients with atopic asthma.Assessment of the frequency of genetic alterations (LOH/MSI) in patients with intraepithelial cervical lesions with HPV infection: a pilot study.Expression of HIF-1A/VEGF/ING-4 Axis in Pulmonary Sarcoidosis.HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.CTLA-4 polymorphisms (+49 A/G and -318 C/T) are important genetic determinants of AITD susceptibility and predisposition to high levels of thyroid autoantibodies in Polish children - preliminary study.Association of Trp64Arg polymorphism of beta3-adrenergic receptor with insulin resistance in Polish children with obesity.Immunoexpression analysis of selected JAK/STAT pathway molecules in patients with non- small-cell lung cancer.Expression analysis of three miRNAs, miR-26a, miR-29b and miR-519d, in relation to MMP-2 expression level in non-small cell lung cancer patients: a pilot study.Expression level and methylation status of three tumor suppressor genes, DLEC1, ITGA9 and MLH1, in non-small cell lung cancer.Expression analysis of selected classes of circulating exosomal miRNAs in soccer players as an indicator of adaptation to physical activity.TGF-β and SMADs mRNA Expression in Pulmonary Sarcoidosis.Single nucleotide polymorphisms in the STAT3 gene influence AITD susceptibility, thyroid autoantibody levels, and IL6 and IL17 secretion.STAT3 rs3816769 polymorphism correlates with gene expression level and may predispose to nonsmall cell lung cancer: a preliminary study.Aberrant methylation as a main mechanism of TSGs silencing in PTC.The Expression Levels of IL-4/IL-13/STAT6 Signaling Pathway Genes and SOCS3 Could Help to Differentiate the Histopathological Subtypes of Non-Small Cell Lung Carcinoma
P50
Q34066293-C0FE3DA9-1A30-48A2-8A58-9FA001D26876Q35894467-201333E6-5009-4E80-B302-EB90FEF3A8C1Q36105659-580CCE91-D419-4C2A-A182-DDDA445A960DQ36127251-1D2D6190-9265-4504-B94E-E14108ABA302Q36879010-276FDB78-6165-4F67-BF78-68CB7140C8F4Q36886177-144C9381-C95D-453D-A01B-29F991D1500AQ37044252-208ED5AC-C551-4F61-85FE-1EB79C13ADF2Q37330746-98F34701-2361-48F6-8C51-3F6304424600Q37825151-849DE325-FA73-41ED-A875-3EAFF4D0C8FCQ38005919-96C4353F-FC47-4A53-AC98-2B3653CBB0C3Q40092918-FE943CD5-36B0-4D29-BAA1-43CCACE0F9DBQ40709466-E1766E6A-C5A8-44B4-9F66-CA0A6F575661Q40891490-707C1AAB-2CFC-4452-8734-3069F51A25D2Q42242723-AF5C1D2D-EAEC-41C3-B281-993F1FD7E65BQ43563669-1C7B51B9-06AE-4A14-9DD1-6B5E26089A1FQ46637172-E6D7A44E-1201-472C-97D6-4207F7E9C386Q47707870-A547835D-0B57-4BD2-ABFC-538411FA93ADQ48146319-41C41170-A5E7-4248-8869-083E924C199CQ48204973-E5CE406B-7B88-479B-A074-F65E589A765DQ50323403-46421BA9-E190-48FC-BC27-0E0439BA99A7Q53589657-A07427F4-AE28-4328-B29E-FA225BE013F3Q54257235-0B46B1C1-9476-4256-BC5A-D357C1CA1B20Q54379853-A135AA91-FB32-4674-AC87-AB65DD26CBD5Q54394561-4A2B8778-E3BF-4579-BDD6-89EE96523612Q58784339-16E9392A-CD37-4472-BB80-9AB1149E1A0A
P50
description
Polish molecular biologist
@en
Pools moleculair biologe
@nl
polska biolog molekularna
@pl
name
Dorota Pastuszak-Lewandoska
@ast
Dorota Pastuszak-Lewandoska
@ca
Dorota Pastuszak-Lewandoska
@cs
Dorota Pastuszak-Lewandoska
@en
Dorota Pastuszak-Lewandoska
@es
Dorota Pastuszak-Lewandoska
@ga
Dorota Pastuszak-Lewandoska
@gl
Dorota Pastuszak-Lewandoska
@hr
Dorota Pastuszak-Lewandoska
@hsb
Dorota Pastuszak-Lewandoska
@it
type
label
Dorota Pastuszak-Lewandoska
@ast
Dorota Pastuszak-Lewandoska
@ca
Dorota Pastuszak-Lewandoska
@cs
Dorota Pastuszak-Lewandoska
@en
Dorota Pastuszak-Lewandoska
@es
Dorota Pastuszak-Lewandoska
@ga
Dorota Pastuszak-Lewandoska
@gl
Dorota Pastuszak-Lewandoska
@hr
Dorota Pastuszak-Lewandoska
@hsb
Dorota Pastuszak-Lewandoska
@it
altLabel
Dorota Izabela Pastuszak-Lewandoska
@pl
prefLabel
Dorota Pastuszak-Lewandoska
@ast
Dorota Pastuszak-Lewandoska
@ca
Dorota Pastuszak-Lewandoska
@cs
Dorota Pastuszak-Lewandoska
@en
Dorota Pastuszak-Lewandoska
@es
Dorota Pastuszak-Lewandoska
@ga
Dorota Pastuszak-Lewandoska
@gl
Dorota Pastuszak-Lewandoska
@hr
Dorota Pastuszak-Lewandoska
@hsb
Dorota Pastuszak-Lewandoska
@it
P214
P1053
S-9465-2016
P1412
P1559
Dorota Pastuszak-Lewandoska
@pl
P21
P214
P27
P31
P3124
P3829
P496
0000-0001-7602-9203
P7859
viaf-311811890